HCC prediction models in chronic hepatitis B patients receiving entecavir or tenofovir: a systematic review and meta-analysis

BACKGROUND: Our study aimed to compare the predictive performance of different hepatocellular carcinoma (HCC) prediction models in chronic hepatitis B patients receiving entecavir or tenofovir, including discrimination, calibration, negative predictive value (NPV) in low-risk, and proportion of low-...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaolan, Jiang, Lushun, Zeng, Yifan, Pan, Liya, Lou, Zhuoqi, Ruan, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428529/
https://www.ncbi.nlm.nih.gov/pubmed/37582759
http://dx.doi.org/10.1186/s12985-023-02145-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428529/
https://www.ncbi.nlm.nih.gov/pubmed/37582759
http://dx.doi.org/10.1186/s12985-023-02145-5

Ejemplares similares